CTOs on the Move

Emendo Biotherapeutics

www.emendobio.com

 
Emendo biotherapeutics develops next generation gene editing tools for genetic disorders, addressing the current technological gaps for realizing the promise of gene therapy.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Emendo Biotherapeutics raised $61M on 01/15/2020

Similar Companies

Oncologie

Oncologie is a global oncology biotech company dedicated to biomarker-driven development of large & small molecules.

RxElite (Main)

RxElite (Main) is a Meridian, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LifeWays

LifeWays is the Community Mental Health Agency for Jackson and Hillsdale Counties. We provide specialty mental health services to individuals with Medicaid or Healthy Michigan, living in Jackson or Hillsdale County. Once someone receives a screenin...

Trevi Therapeutics

Trevi Therapeutics, Inc. is a late-stage clinical development company developing Nalbuphine® ER for chronic pruritus (itch). Pruritus develops in various dermatologic, metabolic, hematologic, and neuropathic conditions. The Company is pursuing two conditions for clinical development: uremic pruritus and prurigo nodularis. Uremic pruritus is a persistent and debilitating itch in patients on dialysis that has been associated with significant impairment in quality of life and increased mortality. Prurigo nodularis is an intensely pruritic dermatologic condition characterized by unsightly and itchy skin papules and nodules. There are no approved therapies in the United States or Europe for either condition.

Moog Medical

Moog Medical designs reliable and easy-to-use CURLIN infusion and Infinity enteral feeding pumps that allow our patients to live life more fully.